Latest Coronary artery disease Stories

CINCINNATI, Jan. 8, 2013 /PRNewswire/ -- A first-of-its-kind cardiac interventional device that dissolves after opening blocked arteries is being evaluated in a national research study led by clinical researchers at The Christ Hospital's Lindner Research Center. To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/59645-the-christ-hospital-bioresorbable-scaffold-coronary-artery-disease Absorb(TM), the first drug-eluting, fully...

ABBOTT PARK, Ill., Jan. 8, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) announced today the initiation of the ABSORB III clinical trial in patients in the United States. This randomized, controlled trial is designed to enroll approximately 2,250 patients, the majority in the United States, and compare the performance of Abbott's drug eluting Absorb((TM)) Bioresorbable Vascular Scaffold (BVS) device to the company's XIENCE((TM)) family of drug eluting stents. The start of this trial in the...

NEW YORK, Jan. 2, 2013 /PRNewswire/ -- The FREEDOM trial, the first long-term, comparative study of its kind exclusively for patients with diabetes and advanced multivessel coronary artery disease (CAD) revealed that diabetics with CAD live longer, and are less likely to suffer a non-fatal heart attack, when treated with bypass surgery instead of drug-eluting stents (DES), tiny, medicine-coated mesh tubes that prop open clogged arteries. The findings were presented in the 2012...

“Seasonal Allergic Rhinitis – Pipeline Review, H2 2012” & “Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Review, H2 2012” are the latest reports added to online market research library of RnRMarketResearch.com Dallas, Texas (PRWEB) January 01, 2013 This report provides information on the therapeutic development for Seasonal Allergic Rhinitis & Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with latest updates, and special features...

ReportsnReports.com adds “Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Review, H2 2012” new market research report to its store. Dallas, TX (PRWEB) December 30, 2012 ''Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete...

Factoring in age and specific EKG signs validate the test's utility Although there is a widespread belief among physicians that the exercise treadmill test (ETT) is not reliable in evaluating the heart health of women, UC Davis researchers have found that the test can accurately predict coronary artery disease in women over the age of 65. They also found that two specific electrocardiogram (EKG) indicators of heart stress during an ETT further enhanced its predictive power. Published in...

Pharmacological stress echo identifies donor hearts that would historically have been rejected Hearts previously rejected due to donors' age or other risk factors can now be declared viable for transplantation using pharmacological stress echo, according to research presented at EUROECHO and other Imaging Modalities 2012. The study1 was presented by Dr Tonino Bombardini from Pisa, Italy. EUROECHO and other Imaging Modalities 2012 is the annual meeting of the European Association of...

Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists — including researchers at the Stanford University School of Medicine — taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46. Coronary artery disease is the process by...

Largest coronary artery disease study to date identifies many new genetic regions associated with risk of heart attacks In the largest genetic study of Coronary Artery Disease (CAD) to date, researchers from the CARDIoGRAMplusC4D Consortium report the identification of 15 genetic regions newly associated with the disease, bringing to 46 the number of regions associated with CAD risk. The team identified a further 104 independent genetic variants that are very likely to be associated...

CHICAGO, Nov. 28, 2012 /PRNewswire-USNewswire/ -- While obesity is considered a cardiovascular risk factor, a study presented today at the annual meeting of the Radiological Society of North America (RSNA) showed that African-American patients with coronary artery disease (CAD) have much less fat around their hearts compared to Caucasian patients. "Prior evidence suggests that increased fat around the heart may be either an independent marker of CAD burden or a predictor of the...